Geert Vanden Bossche | OMICS International

Journal of Molecular Immunology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Geert Vanden Bossche

Head of Vaccine Development Office, German Center for Infection Research, University Clinic Cologne, Joseph- Stelzmann-Str. 9b, D-50931 Cologne

Re-thinking Vaccinology: “Act Universally, Think NK Cells”?

Traditional and modern vaccines that are currently licensed for commercial use have proven safe and effective in fighting several infectious diseases; they are unquestionably among the most efficient tools for promoting individual, public and global health. However, the vaccine field is still facing important shortcomings in that the use of vaccine... Read More»

Geert Vanden Bossche

Review Article: J Mol Immunol 2017, 2: 112

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article